Literature DB >> 6202194

The role of enzyme lysyl amino groups in the reaction with alpha 2-macroglobulin.

R D Feinman, D Wang, S R Windwer, K Wu.   

Abstract

The primary observation, from our laboratory and others, of the effect of blocking the lysyl amino groups of enzymes is the reduction in the fraction of complexes that are resistant to SDS. The blocked enzyme derivatives do cause the specific proteolysis of the alpha 2M subunit to the 85K/100K fragments, and do cause the appearance of new thiol groups. With respect to the sequence of reaction, we may summarize the results by saying that if the reversible DMM-trypsin is, in fact, a model for the native enzyme, proteolysis can precede formation of the presumed covalent bond between bound enzyme and inhibitor. If our preliminary observations are borne out by later experiments, thiol release may precede covalent bond formation or loss of reactivity with amines, suggesting that an intact thiolester need not be the immediate target for amines; another intermediate, possibly the internal pyroglutamate originally proposed by Howard et al. and seen in model studies, may be an additional, or even the primary, target for covalent bonding with native enzymes. With regard to the "trap" hypothesis, the limited release of thiols in a slow phase is suggestive of enzyme activity within the alpha 2M-protease complex, consistent with the theory. Noncovalent irreversible complexes, however, are not a necessary part of associations seen with lysyl-blocked enzymes (which do cause proteolysis and do release thiols); this result is supported by limited data with noncovalently bound native enzymes. Some fraction of irreversible noncovalently bound enzymes may occur, but our results suggest that although alpha 2M-bound enzymes are unusually sterically hindered, the transformation to the presumed covalent state that appears to depend on intact amino groups, may be sufficient to explain the low dissociation of native enzymes. We feel that more experimental evidence is needed to resolve some of the ambiguities on this question but, we feel the existence of a "trapping" reaction has not been proved. In fact, given the possible existence of equilibria between covalent and noncovalent complexes observed, for example, in soybean trypsin inhibitor, and the very low dissociation constants observed with traditional protein-protein complexes, the question of physically encapsulated structures in alpha 2M may not be resolvable without direct evidence from crystal structures.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6202194     DOI: 10.1111/j.1749-6632.1983.tb18108.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.

Authors:  Andrey A Komissarov; Galina Florova; Ali Azghani; Sophia Karandashova; Anna K Kurdowska; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-30       Impact factor: 5.464

2.  The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

Authors:  Andrey A Komissarov; Galina Florova; Ali O Azghani; Ann Buchanan; William M Bradley; Chris Schaefer; Kathleen Koenig; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

3.  Kinetics of the reaction of thrombin and alpha 2-macroglobulin.

Authors:  R D Feinman; A I Yuan; S R Windwer; D Wang
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

4.  Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. III. Electrophoretic protein fractions, trypsin-inhibitory capacity, alpha 1-proteinase inhibitor, and alpha 1- and alpha 2-macroglobulin proteinase inhibitors of culture fluids and serum.

Authors:  S Harada; A M Dannenberg; R F Vogt; J E Myrick; F Tanaka; L C Redding; R M Merkhofer; P J Pula; A L Scott
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.